161 related articles for article (PubMed ID: 23064035)
21. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
[TBL] [Abstract][Full Text] [Related]
22. Duloxetine Attenuates Paclitaxel-Induced Peripheral Nerve Injury by Inhibiting p53-Related Pathways.
Lu Y; Zhang P; Zhang Q; Yang C; Qian Y; Suo J; Tao X; Zhu J
J Pharmacol Exp Ther; 2020 Jun; 373(3):453-462. PubMed ID: 32238452
[TBL] [Abstract][Full Text] [Related]
23. The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial.
Avan R; Janbabaei G; Hendouei N; Alipour A; Borhani S; Tabrizi N; Salehifar E
J Res Med Sci; 2018; 23():52. PubMed ID: 30057636
[TBL] [Abstract][Full Text] [Related]
24. [A case of paclitaxel-induced peripheral neuropathy successfully treated with pregabalin].
Nakashima T; Kiba T; Ogawa Y; Hosokawa A; Shintani H; Okada Y; Taniguchi T; Shigeta M; Kozawa K
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1443-5. PubMed ID: 22996788
[TBL] [Abstract][Full Text] [Related]
25. Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care.
Gore M; Zlateva G; Tai KS; Chandran AB; Leslie D
Pain Pract; 2011; 11(2):167-79. PubMed ID: 20723096
[TBL] [Abstract][Full Text] [Related]
26. Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.
Hirayama Y; Ishitani K; Sato Y; Iyama S; Takada K; Murase K; Kuroda H; Nagamachi Y; Konuma Y; Fujimi A; Sagawa T; Ono K; Horiguchi H; Terui T; Koike K; Kusakabe T; Sato T; Takimoto R; Kobune M; Kato J
Int J Clin Oncol; 2015 Oct; 20(5):866-71. PubMed ID: 25762165
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Duloxetine on electrodiagnostic findings of Paclitaxel-induced peripheral neuropathy, does it have a prophylactic effect? A randomized clinical trial.
Aghabozorgi R; Hesam M; Zahed G; Babaee M; Hashemi M; Rayegani SM
Anticancer Drugs; 2023 Jun; 34(5):680-685. PubMed ID: 36730548
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and safety of pregabalin for oxaliplatin- and paclitaxel-induced peripheral neuropathy].
Nihei S; Sato J; Kashiwaba M; Itabashi T; Kudo K; Takahashi K
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1189-93. PubMed ID: 24047777
[TBL] [Abstract][Full Text] [Related]
29. Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats.
Yamamoto S; Kawashiri T; Higuchi H; Tsutsumi K; Ushio S; Kaname T; Shirahama M; Egashira N
J Pharmacol Sci; 2015 Sep; 129(1):43-50. PubMed ID: 26362518
[TBL] [Abstract][Full Text] [Related]
30. Gabapentin and Duloxetine Prevent Oxaliplatin- and Paclitaxel-Induced Peripheral Neuropathy by Inhibiting Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Phosphorylation in Spinal Cords of Mice.
Kato N; Tateishi K; Tsubaki M; Takeda T; Matsumoto M; Tsurushima K; Ishizaka T; Nishida S
Pharmaceuticals (Basel); 2020 Dec; 14(1):. PubMed ID: 33396362
[TBL] [Abstract][Full Text] [Related]
31. A Prospective Observational Study Comparing the Efficacy and Safety of Duloxetine and Pregabalin in Diabetic Peripheral Neuropathic Pain.
Shah I; Ahmad W; Islam M; Jan B; Ul Haq E; Mahmood J; Iqbal N; Shah M
Cureus; 2022 Sep; 14(9):e28683. PubMed ID: 36199645
[TBL] [Abstract][Full Text] [Related]
32. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
Smith EM; Pang H; Ye C; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Le-Lindqwister N; Fadul CE; Loprinzi C; Shapiro CL;
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26603828
[TBL] [Abstract][Full Text] [Related]
33. A study on comparative efficacy and cost effectiveness of Pregabalin and Duloxetine used in diabetic neuropathic pain.
Roy MK; Kuriakose AS; Varma SK; Jacob LA; Beegum NJ
Diabetes Metab Syndr; 2017; 11(1):31-35. PubMed ID: 27484440
[TBL] [Abstract][Full Text] [Related]
34. Role of Collagen Conduit With Duloxetine and/or Pregabalin in the Management of Partial Peripheral Nerve Injury.
Khan J; Alghamdi H; Anwer MM; Eliav E; Ziccardi V
J Oral Maxillofac Surg; 2016 Jun; 74(6):1120-30. PubMed ID: 26878362
[TBL] [Abstract][Full Text] [Related]
35. Predictors of the usefulness of duloxetine for chemotherapy-induced peripheral neuropathy.
Kanbayashi Y; Inagaki M; Ueno H; Hosokawa T
Med Oncol; 2017 Aug; 34(8):137. PubMed ID: 28687964
[TBL] [Abstract][Full Text] [Related]
36. A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.
Ellis JJ; Sadosky AB; Ten Eyck LL; Mudumby P; Cappelleri JC; Ndehi L; Suehs BT; Parsons B
BMC Health Serv Res; 2015 Apr; 15():159. PubMed ID: 25889173
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the Efficacy of Duloxetine and Pregabalin in Pain Relief Associated with Diabetic Neuropathy.
Shahid W; Kumar R; Shaikh A; Kumar S; Jameel R; Fareed S
Cureus; 2019 Jul; 11(7):e5293. PubMed ID: 31579634
[TBL] [Abstract][Full Text] [Related]
38. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
[TBL] [Abstract][Full Text] [Related]
39. [Chemotherapy-induced peripheral neuropathy and neuropathic pain].
Schuler U; Heller S
Schmerz; 2017 Aug; 31(4):413-425. PubMed ID: 28293734
[TBL] [Abstract][Full Text] [Related]
40. Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-κB.
Meng J; Zhang Q; Yang C; Xiao L; Xue Z; Zhu J
Front Pharmacol; 2019; 10():365. PubMed ID: 31024320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
